Project Title: The role of novel AIP1 isoform in pathological lymphangiogenesis Abstract The lymphatic system collects extravasated fluid, macromolecules, and immune cells from tissues and returns them to the blood circulation. VEGFR3 is critical for lymphangiogenesis. Extensive studies have thus far focused on the role of VEGFR3 in lymphangiogenesis during development, however the function, regulation and intracellular mediators of the VEGFR3-dependent pathways in lymphatic vessels during cardiovascular diseases remain poorly characterized. In our previous funding cycle, we identified a novel member of signal scaffolding molecule AIP1 as a potent regulator in pathological angiogenesis. Human genome-wide association study (GWAS) has identified an AIP1 gene variant conferring susceptibility to cardiovascular diseases including peripheral vascular disease and early onset of myocardial infarction. Our data show that mice with a global or EC-specific deletion of AIP1 exhibited enhanced inflammation, angiogenesis and arteriogenesis in ischemic tissues. To our surprise, AIP1-deficient mice exhibited reduced lymphangiogenesis, correlating with reduced expression and activity of VEGFR3 in AIP1-deficient lymphatic tissues and lymphatic endothelial cells (LECs). We have identified a novel isoform of AIP1L which is specifically expressed in LECs. AIP1L is specifically localized on cytoplasmic membrane in LECs where it strongly activates VEGFR3 signaling. We propose the following aims to define the role of the novel isoform AIP1L in pathological lymphangiogenesis: 1. Elucidate the mechanisms by which AIP1L promotes lymphangiogenic signaling. We will determine if AIP1L facilitates endocytosis and recycling to cytoplasm membrane. 2. Define the mechanism for AIP1L gene regulation in lymphatic vessels. We will determine how the RIF1/H3K9 methylation complex and LEC transcriptional factors epigenetically regulate AIP1L transcription. 3. Determine the function of AIP1L in pathological lymphangiogenesis. We will use newly created mice with AIP1L deletion or transgene to determine if the role of AIP1 isoform in pathological lymphangiogenesis and tissue repair.

Public Health Relevance

Lymphatic vessel actively regulates tissue fluid homeostasis, absorption of gastrointestinal lipids, and trafficking of antigen-presenting cells and lymphocytes to lymphoid organs and on to the systemic circulation. Abnormal function of lymphatics is involved in a variety of diseases such as inflammation, lymphedema, myocardial infarction. We will investigate the expression and function of newly identified AIP1L molecule during pathological lymphangiogenic and tissue repair. Therefore, our study will evaluate if a novel molecule AIP1L represents a novel therapeutic target to control lymphangiogenesis-dependent vascular diseases.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL115148-06
Application #
9676341
Study Section
Vascular Cell and Molecular Biology Study Section (VCMB)
Program Officer
Gao, Yunling
Project Start
2013-08-01
Project End
2022-05-31
Budget Start
2019-06-01
Budget End
2020-05-31
Support Year
6
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Yale University
Department
Pathology
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Zhou, Huanjiao Jenny; Xu, Zhe; Wang, Zongren et al. (2018) SUMOylation of VEGFR2 regulates its intracellular trafficking and pathological angiogenesis. Nat Commun 9:3303
He, Li; Pierce, Richard W; Min, Wang (2018) Rare and Low-Frequency Variant of ARHGEF17 Is Associated With Intracranial Aneurysms. Circ Genom Precis Med 11:e002248
Liu, Tingting; Zhou, Huanjiao Jenny; Min, Wang (2017) ASK family in cardiovascular biology and medicine. Adv Biol Regul 66:54-62
Tan, Shu; Feng, Boya; Yin, Mingzhu et al. (2017) Stromal Senp1 promotes mouse early folliculogenesis by regulating BMP4 expression. Cell Biosci 7:36
Yin, Mingzhu; Zhou, Huanjiao Jenny; Zhang, Jiqin et al. (2017) ASK1-dependent endothelial cell activation is critical in ovarian cancer growth and metastasis. JCI Insight 2:
Zhu, Xiaolong; Ding, Sha; Qiu, Cong et al. (2017) SUMOylation Negatively Regulates Angiogenesis by Targeting Endothelial NOTCH Signaling. Circ Res 121:636-649
Chen, Chaofei; Li, Li; Zhou, Huanjiao Jenny et al. (2017) The Role of NOX4 and TRX2 in Angiogenesis and Their Potential Cross-Talk. Antioxidants (Basel) 6:
Qiu, Cong; Wang, Yuewen; Zhao, Haige et al. (2017) The critical role of SENP1-mediated GATA2 deSUMOylation in promoting endothelial activation in graft arteriosclerosis. Nat Commun 8:15426
Shao, Lan; Feng, Boya; Zhang, Yuying et al. (2016) The role of adipose-derived inflammatory cytokines in type 1 diabetes. Adipocyte 5:270-4
Jenny Zhou, Huanjiao; Qin, Lingfeng; Zhang, Haifeng et al. (2016) Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation. Nat Med 22:1033-1042

Showing the most recent 10 out of 28 publications